/
LEGN
$20.27-$0.38 (-1.84%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.0B
194M shares
52-week range
$16.24 – $38.35
18% from low
Exchange
NASDAQ
ADRC
Change$-18.71
Legend Biotech Corporation American Depositary Shares
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
www.legendbiotech.com- Employees
- 3,100
- IPO / List date
- Jun 5, 2020
Held by traders on TradeandTell
No one on the platform currently holds LEGN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 521,800 | $9.4M |
| Bridgewater Associatesas of 2025-03-31 | 225,449 | $7.6M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded LEGN yet.
